LTC3207941I2 - - Google Patents
Info
- Publication number
- LTC3207941I2 LTC3207941I2 LTPA2021507C LTPA2021507C LTC3207941I2 LT C3207941 I2 LTC3207941 I2 LT C3207941I2 LT PA2021507 C LTPA2021507 C LT PA2021507C LT PA2021507 C LTPA2021507 C LT PA2021507C LT C3207941 I2 LTC3207941 I2 LT C3207941I2
- Authority
- LT
- Lithuania
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5403—IL-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/202—IL-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/642—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a cytokine, e.g. IL2, chemokine, growth factors or interferons being the inactive part of the conjugate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84347106P | 2006-09-07 | 2006-09-07 | |
| US93277207P | 2007-06-01 | 2007-06-01 | |
| PCT/US2007/019481 WO2008030539A2 (en) | 2006-09-07 | 2007-09-07 | Methods and compositions based on diphtheria toxin-interleukin-3 conjugates |
| EP07837840.3A EP2063907B1 (en) | 2006-09-07 | 2007-09-07 | Methods and compositions based on diphtheria toxin-interleukin-3 conjugates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LTPA2021507I1 LTPA2021507I1 (lt) | 2021-06-10 |
| LTC3207941I2 true LTC3207941I2 (lt) | 2022-10-10 |
Family
ID=39157851
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP17151480.5T LT3207941T (lt) | 2006-09-07 | 2007-09-07 | Būdai ir kompozicijos difterijos toksino ir interleukino 3 konjugatų pagrindu |
| LTPA2021507C LTC3207941I2 (lt) | 2006-09-07 | 2021-05-12 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP17151480.5T LT3207941T (lt) | 2006-09-07 | 2007-09-07 | Būdai ir kompozicijos difterijos toksino ir interleukino 3 konjugatų pagrindu |
Country Status (17)
| Country | Link |
|---|---|
| US (7) | US7763242B2 (lt) |
| EP (3) | EP2063907B1 (lt) |
| JP (6) | JP5550905B2 (lt) |
| AU (1) | AU2007293047B2 (lt) |
| CA (5) | CA2923381A1 (lt) |
| CY (2) | CY1119654T1 (lt) |
| DK (2) | DK3207941T6 (lt) |
| ES (2) | ES2781402T7 (lt) |
| FR (1) | FR21C1017I2 (lt) |
| HU (2) | HUE048356T2 (lt) |
| LT (2) | LT3207941T (lt) |
| LU (1) | LUC00206I2 (lt) |
| NL (1) | NL301103I2 (lt) |
| PL (2) | PL2063907T3 (lt) |
| PT (1) | PT3207941T (lt) |
| SI (1) | SI3207941T1 (lt) |
| WO (1) | WO2008030539A2 (lt) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8969372B2 (en) | 2003-11-14 | 2015-03-03 | Aptose Boisciences Inc. | Aryl imidazoles and their use as anti-cancer agents |
| HUE048356T2 (hu) | 2006-09-07 | 2020-07-28 | Scott & White Memorial Hospital | Diftéria-toxin-interleukin-3 konjugátumokon alapuló eljárások és készítmények |
| WO2010027802A2 (en) | 2008-08-25 | 2010-03-11 | New York University | Methods for treating diabetic wounds |
| EP2352526A1 (en) * | 2008-09-19 | 2011-08-10 | Protox Therapeutics Inc. | Treating cancer stem cells using targeted cargo proteins |
| JP6018507B2 (ja) * | 2010-02-17 | 2016-11-02 | シーエスエル、リミテッド | Ｉ型インターフェロン産生細胞を標的化するための組成物及び方法 |
| WO2011160082A2 (en) | 2010-06-17 | 2011-12-22 | New York University | Therapeutic and cosmetic uses and applications of calreticulin |
| WO2012019061A2 (en) | 2010-08-05 | 2012-02-09 | Stem Centrx, Inc. | Novel effectors and methods of use |
| KR20140018837A (ko) | 2010-08-27 | 2014-02-13 | 스템 센트알엑스 인코포레이티드 | 노텀 단백질 조절 인자 및 사용 방법 |
| US9458231B2 (en) | 2010-09-03 | 2016-10-04 | Stemcentrx, Inc. | Modulators and methods of use |
| TWI585106B (zh) | 2010-12-08 | 2017-06-01 | 艾伯維史坦森特瑞斯有限責任公司 | 新穎調節劑及其使用方法 |
| SA112330278B1 (ar) | 2011-02-18 | 2015-10-09 | ستيم سينتركس، انك. | مواد ضابطة جديدة وطرق للاستخدام |
| CA2840989A1 (en) | 2011-07-06 | 2013-01-10 | Novartis Ag | Immunogenic combination compositions and uses thereof |
| US20130058947A1 (en) | 2011-09-02 | 2013-03-07 | Stem Centrx, Inc | Novel Modulators and Methods of Use |
| EP2817338B1 (en) | 2012-02-24 | 2017-07-26 | AbbVie Stemcentrx LLC | Dll3 modulators and methods of use |
| MX2014010094A (es) | 2012-02-24 | 2014-09-16 | Stem Centrx Inc | Anticuerpos anti-homologo relacionado con las convulsiones 6 (anti-sez6) y metodos de uso. |
| AU2014218730B2 (en) | 2013-02-22 | 2018-12-13 | Abbvie Stemcentrx Llc | Novel antibody conjugates and uses thereof |
| CA2922547C (en) | 2013-08-28 | 2020-03-10 | Stemcentrx, Inc. | Site-specific antibody conjugation methods and compositions |
| WO2015031541A1 (en) | 2013-08-28 | 2015-03-05 | Stem Centrx, Inc. | Novel sez6 modulators and methods of use |
| JP6946000B2 (ja) | 2013-10-04 | 2021-10-06 | アプトース バイオサイエンシーズ， インコーポレイテッド | がんの治療用組成物及び方法 |
| PE20160870A1 (es) | 2013-11-06 | 2016-09-09 | Abbvie Stemcentrx Llc | Anticuerpos anti-claudina novedosos y metodos de uso |
| JP2017500028A (ja) | 2013-12-12 | 2017-01-05 | アッヴィ・ステムセントルクス・エル・エル・シー | 新規の抗ｄｐｅｐ３抗体および使用方法 |
| EP3107576A4 (en) | 2014-02-21 | 2017-09-06 | Abbvie Stemcentrx LLC | Anti-dll3 antibodies and drug conjugates for use in melanoma |
| RU2708075C2 (ru) | 2014-04-30 | 2019-12-04 | Пфайзер Инк. | Конъюгаты анти-ртк7 антитело-лекарственное средство |
| TW201617368A (zh) | 2014-09-05 | 2016-05-16 | 史坦森特瑞斯公司 | 新穎抗ｍｆｉ２抗體及使用方法 |
| AU2017254674A1 (en) | 2016-04-21 | 2018-11-01 | Abbvie Stemcentrx Llc | Novel anti-BMPR1B antibodies and methods of use |
| CN107793481A (zh) * | 2016-08-31 | 2018-03-13 | 南京传奇生物科技有限公司 | 一种靶向人cd123的嵌合受体配体及其应用 |
| WO2019089511A1 (en) | 2017-10-30 | 2019-05-09 | Aptose Biosciences Inc. | Aryl imidazoles for the treatment of cancer |
| US20210361744A1 (en) * | 2018-04-27 | 2021-11-25 | Stemline Therapeutics, Inc. | Methods of Treating an Autoimmune Disease with a Human Interleukin-3 (IL-3)-Diphtheria Toxin Conjugate (DT-IL3) |
| EP3802834A4 (en) * | 2018-05-30 | 2022-08-03 | The Governing Council of the University of Toronto | METHODS AND KITS FOR IDENTIFYING A PROTEIN ASSOCIATED WITH RECEPTOR-LIGAND INTERACTIONS |
| BR112021007945A2 (pt) | 2018-10-31 | 2021-08-03 | Stemline Therapeutics, Inc. | método de terapia de combinação para tratar neoplasmas mieloproliferativos com um conjugado de toxina de difteria-interleucina-3 humana em combinação com outros agentes |
| WO2020112642A1 (en) | 2018-11-30 | 2020-06-04 | Stemline Therapeutics, Inc. | Improved methods of treating myeloproliferative neoplasms with a diphtheria toxin-human interleukin-3 conjugate |
| WO2021099573A1 (en) * | 2019-11-21 | 2021-05-27 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and compositions for diagnosing and treating chronic myelomonocytic leukemia (cmml) |
| KR20230146515A (ko) | 2020-12-10 | 2023-10-19 | 스템라인 테라퓨틱스, 인코포레이티드 | 개선된 동결건조 제형 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU573529B2 (en) | 1982-05-12 | 1988-06-16 | President And Fellows Of Harvard College | Hybrid proteins |
| US5080898A (en) | 1982-05-12 | 1992-01-14 | The University Hospital | Enzymatically active toxin coupled to a cell-specific ligand |
| US5668255A (en) | 1984-06-07 | 1997-09-16 | Seragen, Inc. | Hybrid molecules having translocation region and cell-binding region |
| US6022950A (en) | 1984-06-07 | 2000-02-08 | Seragen, Inc. | Hybrid molecules having translocation region and cell-binding region |
| US5128326A (en) | 1984-12-06 | 1992-07-07 | Biomatrix, Inc. | Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same |
| WO1991006287A1 (en) | 1989-11-06 | 1991-05-16 | Enzytech, Inc. | Protein microspheres and methods of using them |
| JP3311346B2 (ja) | 1990-03-02 | 2002-08-05 | ボストン・メディカル・センター・コーポレーション | 改良されたキメラ毒素 |
| US5698155A (en) | 1991-05-31 | 1997-12-16 | Gs Technologies, Inc. | Method for the manufacture of pharmaceutical cellulose capsules |
| DE4121547A1 (de) | 1991-06-28 | 1993-01-14 | Daimler Benz Ag | Mehrschichtisolierfolie |
| US6162432A (en) | 1991-10-07 | 2000-12-19 | Biogen, Inc. | Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction |
| DE4140121C2 (de) | 1991-12-05 | 1994-06-30 | Manfred Mueller | Verfahren zum Herstellen von gefaßten, gegossenen Schmuckstücken |
| US5912015A (en) | 1992-03-12 | 1999-06-15 | Alkermes Controlled Therapeutics, Inc. | Modulated release from biocompatible polymers |
| US5441050A (en) | 1992-12-18 | 1995-08-15 | Neoprobe Corporation | Radiation responsive surgical instrument |
| WO1996038571A2 (en) * | 1995-05-31 | 1996-12-05 | Regents Of The University Of Minnesota | Recombinant polypeptide cytotoxins for cancer treatment |
| CA2230494A1 (en) | 1995-08-31 | 1997-03-06 | Alkermes Controlled Therapeutics Inc. | Composition for sustained release of an agent |
| US5843633A (en) | 1996-04-26 | 1998-12-01 | Amcell Corporation | Characterization of a human hematopoietic progenitor cell antigen |
| US20040013664A1 (en) | 1997-01-14 | 2004-01-22 | Gentz Reiner L. | Tumor necrosis factor receptors 6 alpha & 6 beta |
| US6004528A (en) | 1997-09-18 | 1999-12-21 | Bergstein; Ivan | Methods of cancer diagnosis and therapy targeted against the cancer stemline |
| US7361336B1 (en) | 1997-09-18 | 2008-04-22 | Ivan Bergstein | Methods of cancer therapy targeted against a cancer stem line |
| US5989463A (en) | 1997-09-24 | 1999-11-23 | Alkermes Controlled Therapeutics, Inc. | Methods for fabricating polymer-based controlled release devices |
| SE512663C2 (sv) | 1997-10-23 | 2000-04-17 | Biogram Ab | Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer |
| US7030228B1 (en) | 1999-11-15 | 2006-04-18 | Miltenyi Biotec Gmbh | Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| AU779803B2 (en) | 1999-12-03 | 2005-02-10 | Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland, The | Dendritic cell-specific antibodies |
| ATE510855T1 (de) | 2000-03-06 | 2011-06-15 | Univ Kentucky Res Found | Verwendung eines antikörpers oder eines immunotoxins, der bzw. das selektiv an cd123 bindet zur beeinträchtigung hämatologischer krebs-vorläuferzellen |
| AU2002250236A1 (en) | 2001-03-02 | 2002-09-19 | Medimmune, Inc. | Cd2 antagonists for treatment of autoimmune or inflammatory disease |
| WO2002070007A1 (en) | 2001-03-02 | 2002-09-12 | Medimmune, Inc. | Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| US7354584B2 (en) | 2003-04-11 | 2008-04-08 | Medimmune, Inc. | Recombinant IL-9 antibodies |
| HUE048356T2 (hu) * | 2006-09-07 | 2020-07-28 | Scott & White Memorial Hospital | Diftéria-toxin-interleukin-3 konjugátumokon alapuló eljárások és készítmények |
| AU2014201901B2 (en) | 2006-09-07 | 2016-05-05 | Scott & White Healthcare | Methods and compositions based on diphtheria toxin-interleukin-3 conjugates |
| US8163279B2 (en) | 2007-04-13 | 2012-04-24 | Stemline Therapeutics, Inc. | IL3Rα antibody conjugates and uses thereof |
| CN104245720A (zh) | 2012-02-29 | 2014-12-24 | Ambrx公司 | 白细胞介素-3多肽结合物和其用途 |
-
2007
- 2007-09-07 HU HUE17151480A patent/HUE048356T2/hu unknown
- 2007-09-07 WO PCT/US2007/019481 patent/WO2008030539A2/en active Application Filing
- 2007-09-07 LT LTEP17151480.5T patent/LT3207941T/lt unknown
- 2007-09-07 PL PL07837840T patent/PL2063907T3/pl unknown
- 2007-09-07 DK DK17151480.5T patent/DK3207941T6/da active
- 2007-09-07 DK DK07837840.3T patent/DK2063907T3/da active
- 2007-09-07 CA CA2923381A patent/CA2923381A1/en not_active Abandoned
- 2007-09-07 US US11/899,747 patent/US7763242B2/en active Active
- 2007-09-07 ES ES17151480T patent/ES2781402T7/es active Active
- 2007-09-07 ES ES07837840.3T patent/ES2646545T3/es active Active
- 2007-09-07 AU AU2007293047A patent/AU2007293047B2/en active Active
- 2007-09-07 CA CA3053981A patent/CA3053981C/en active Active
- 2007-09-07 CA CA3153438A patent/CA3153438C/en active Active
- 2007-09-07 PT PT171514805T patent/PT3207941T/pt unknown
- 2007-09-07 CA CA2698595A patent/CA2698595C/en active Active
- 2007-09-07 EP EP07837840.3A patent/EP2063907B1/en active Active
- 2007-09-07 PL PL17151480T patent/PL3207941T6/pl unknown
- 2007-09-07 CA CA3007075A patent/CA3007075C/en active Active
- 2007-09-07 EP EP19159793.9A patent/EP3520806B1/en active Active
- 2007-09-07 SI SI200732148T patent/SI3207941T1/sl unknown
- 2007-09-07 EP EP17151480.5A patent/EP3207941B3/en active Active
- 2007-09-07 JP JP2009527415A patent/JP5550905B2/ja active Active
-
2009
- 2009-02-09 US US12/368,048 patent/US8470307B2/en active Active
-
2013
- 2013-05-17 US US13/896,923 patent/US9181317B2/en active Active
-
2014
- 2014-04-01 JP JP2014075847A patent/JP5902223B2/ja active Active
-
2015
- 2015-07-17 US US14/802,398 patent/US9631006B2/en active Active
-
2016
- 2016-03-09 JP JP2016045210A patent/JP6336500B2/ja active Active
-
2017
- 2017-03-10 US US15/455,420 patent/US10259853B2/en active Active
- 2017-11-03 CY CY20171101153T patent/CY1119654T1/el unknown
-
2018
- 2018-05-02 JP JP2018088719A patent/JP6654660B2/ja active Active
-
2019
- 2019-02-08 US US16/271,456 patent/US11130792B2/en active Active
-
2020
- 2020-01-30 JP JP2020013230A patent/JP2020079260A/ja active Pending
- 2020-03-23 CY CY20201100271T patent/CY1123035T1/el unknown
-
2021
- 2021-04-22 HU HUS2100013C patent/HUS2100013I1/hu unknown
- 2021-05-11 FR FR21C1017C patent/FR21C1017I2/fr active Active
- 2021-05-12 LU LU00206C patent/LUC00206I2/en unknown
- 2021-05-12 NL NL301103C patent/NL301103I2/nl unknown
- 2021-05-12 LT LTPA2021507C patent/LTC3207941I2/lt unknown
- 2021-08-25 US US17/411,947 patent/US20220235108A1/en active Pending
-
2022
- 2022-02-15 JP JP2022020917A patent/JP2022065089A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTC3207941I2 (lt) | ||
| CN100532764C9 (zh) | 前移旋转避让型载车装置 | |
| CH2121272H1 (lt) | ||
| BY9789C1 (lt) | ||
| CN300725929S (zh) | 童装(3811) | |
| CN300725925S (zh) | 童装(3791) | |
| CN300726198S (zh) | 印花面料(一世情缘一系列) | |
| CN300725943S (zh) | 童装(3876) | |
| CN300725942S (zh) | 童装(3874) | |
| CN300725941S (zh) | 童装(3872) | |
| CN300728277S (zh) | 地暖专用隔热板(3) | |
| CN300725939S (zh) | 童装裤子(3856) | |
| CN300725938S (zh) | 童装(3854) | |
| CN300725937S (zh) | 童装(3852) | |
| CN300725936S (zh) | 童装(3850) | |
| CN300725935S (zh) | 童装裤子(3835) | |
| CN300725934S (zh) | 童装(3833) | |
| CN300725933S (zh) | 童装(3831) | |
| CN300725932S (zh) | 童装(3829) | |
| CN300725931S (zh) | 童装(3815) | |
| CN300725930S (zh) | 童装(3813) | |
| CN300728492S (zh) | 宠物用品(葡萄) | |
| CN300725928S (zh) | 童装(3809) | |
| CN300725927S (zh) | 童装(3795) | |
| CN300725926S (zh) | 童装(3793) |